Patent details

EP3334726 Title: PLINABULIN COMPOSITIONS

Basic Information

Publication number:
EP3334726
PCT Application Number:
US2016041773
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP168249969
PCT Publication Number:
WO2017011399
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PLINABULIN COMPOSITIONS
French Title of Invention:
COMPOSITIONS DE PLINABULINE
German Title of Invention:
PINABULIN-ZUSAMMENSETZUNGEN
SPC Number:

Dates

Filing date:
11/07/2016
Grant date:
16/03/2022
EP Publication Date:
20/06/2018
PCT Publication Date:
19/01/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/03/2022
EP B1 Publication Date:
16/03/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/07/2022
Expiration date:
11/07/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/03/2022
 
 

Name:
Beyondspring Pharmaceuticals, Inc.
Address:
28 Liberty Street, 39th Floor, New York, NY 10005, United States (US)

Inventor

1

Name:
SINGH, Aniruddh
Address:
United States (US)

2

Name:
HUANG, Lan
Address:
United States (US)

Priority

Priority Number:
201562191990 P
Priority Date:
13/07/2015
Priority Country:
United States (US)

Classification

IPC classification:
C07D 403/06;

Publication

European Patent Bulletin

Issue number:
202211
Publication date:
16/03/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages